Bulk Manufacturer of Controlled Substances Application: Ampac Fine Chemicals LLC, 44924-44925 [2020-16104-2]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
44924
Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on September 13, 2018, based on a
complaint, as amended, filed by FCA
US LLC of Auburn Hills, Michigan
(‘‘Complainant’’). See 83 FR 46517
(Sept. 13, 2018). The complaint alleges
violations of section 337 based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain motorized vehicles and
components thereof by reason of: (1)
Infringement of U.S. Trademark
Registration Nos. 4,272,873; 2,862,487;
2,161,779; 2,794,553; and 4,043,984
(collectively, ‘‘the Asserted
Trademarks’’); (2) trademark dilution
and unfair competition in violating the
complainant’s common law trademark
rights; and (3) trade dress infringement.
See id. The notice of investigation
names Mahindra & Mahindra Ltd. of
Mumbai, India and Mahindra
Automotive North America, Inc. of
Auburn Hills, Michigan (collectively,
‘‘Respondents’’) as respondents in this
investigation. See id. The Office of
Unfair Import Investigations is also a
party to this investigation. See id.
The ALJ conducted an evidentiary
hearing on August 19–23, 2019. On
November 8, 2019, the ALJ issued a
final initial determination (‘‘FID’’)
finding a violation of section 337.
Specifically, the FID determined that
Respondents’ Roxor vehicle (2018–2019
model) infringes FCA’s asserted trade
dress but not its Asserted Trademarks.
The FID also determined that
Complainant did not establish
trademark dilution.
On June 11, 2020, the Commission
determined to affirm the FID’s
determination of a violation of section
337. The Commission issued an LEO
barring entry of articles that infringe the
asserted trade dress and a CDO against
both Respondents. The Commission
declined to adjudicate Respondents’
proposed redesigned vehicles and
required Respondents to obtain a ruling
(via an advisory opinion or a
modification proceeding) from the
Commission prior to any importation of
redesigned vehicles or components
thereof.
On June 18, 2020, Respondents filed
a petition for an expedited modification
proceeding as to two redesigned
vehicles, namely the 2020 Roxor vehicle
and the Post-2020 Roxor vehicle.
Respondents further request, should the
Commission determine that the 2020
Roxor vehicle requires more time, that
the Commission institute a modification
VerDate Sep<11>2014
20:45 Jul 23, 2020
Jkt 250001
proceeding only as to the Post-2020
ROXOR vehicle. On June 29, 2020,
Complainant filed a response in
opposition to Respondents’ petition.
OUII did not file a response to the
petition. On July 7, 2020, Respondents
filed a motion for leave to file a reply
in support of their petition for an
expedited modification proceeding,
which is hereby GRANTED.
The Commission has determined to
institute a modification proceeding
under 19 U.S.C. 1337(k) and 19 CFR
210.76 to adjudicate infringement with
respect to Respondents’ Post-2020
ROXOR vehicle. The Commission has
also determined to delegate the
modification proceeding to the Chief
ALJ to designate a presiding ALJ to
make all necessary factual and legal
findings and to issue a recommended
determination as to whether the
Commission shall modify the remedial
orders to explicitly exempt
Respondents’ Post-2020 ROXOR
vehicle. The Commission has further
determined to set the deadline for the
ALJ to issue a recommended
determination to three months from
issuance of this notice. Should the ALJ
determine that more time is necessary,
the deadline may be extended for good
cause shown.
The Commission’s vote on this
determination took place on July 20,
2020.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: July 20, 2020.
Lisa Barton,
Secretary to the Commission.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–686]
Bulk Manufacturer of Controlled
Substances Application: Ampac Fine
Chemicals LLC
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 22, 2020.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Controlled substance
Methylphenidate ............
Levomethorphan ............
Levorphanol ...................
Thebaine ........................
Remifentanil ...................
Tapentadol .....................
Drug
code
1724
9210
9220
9333
9739
9780
Schedule
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances for
distribution to its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–16104 Filed 7–23–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–686]
Bulk Manufacturer of Controlled
Substances Application: Ampac Fine
Chemicals LLC
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 22, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
BILLING CODE 7020–02–P
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2020, Ampac
Fine Chemicals LLC, Highway 50 and
Hazel Avenue, Rancho Cordova,
California 95670, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
ACTION:
[FR Doc. 2020–16028 Filed 7–23–20; 8:45 am]
ACTION:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2020, Ampac
Fine Chemicals LLC, Highway 50 and
Hazel Avenue, Rancho Cordova,
California 95670, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\24JYN1.SGM
24JYN1
Federal Register / Vol. 85, No. 143 / Friday, July 24, 2020 / Notices
Controlled substance
Methylphenidate ............
Levomethorphan ............
Levorphanol ...................
Thebaine ........................
Remifentanil ...................
Tapentadol .....................
Drug
code
1724
9210
9220
9333
9739
9780
Schedule
II
II
II
II
II
II
Drug
code
Controlled substance
Pentobarbital .................
The company plans to manufacture
the listed controlled substances for
distribution to its customers.
William T. McDermott,
Assistant Administrator.
Schedule
2270
II
The facility intends to import the
above-listed controlled substance for
legitimate use. This particular
controlled substance is not available for
the intended legitimate use within the
current domestic supply of the United
States.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–16103 Filed 7–23–20; 8:45 am]
[FR Doc. 2020–16104 Filed 7–23–20; 8:45 am]
BILLING CODE P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
[OMB Number 1110–0055]
Drug Enforcement Administration
Agency Information Collection
Activities; Proposed eCollection;
eComments Requested; The National
Instant Criminal Background Check
System
[Docket No. DEA–685]
Importer of Controlled Substances
Application: Arizona Department of
Corrections
ACTION:
Federal Bureau of
Investigation, Department of Justice.
ACTION: 30-day Notice.
AGENCY:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 24, 2020. Such persons
may also file a written request for a
hearing on the application on or before
August 24, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on June 16, 2020, Arizona
Department of Corrections, 1305 E Butte
Avenue, ASPC-Florence, Florence,
Arizona 85132–9221, applied to be
registered as an importer of the
following basic class(es) of a controlled
substance:
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
20:45 Jul 23, 2020
Jkt 250001
Department of Justice (DOJ),
Federal Bureau of Investigation,
Criminal Justice Information Services
Division will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until August 24, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
SUMMARY:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
44925
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection: The
National Instant Criminal Background
Check System (NICS) Checks by
Criminal Justice Agencies (CJA)
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
1110–0055
(4) Sponsoring component:
Department of Justice, Federal Bureau of
Investigation, Criminal Justice
Information Services Division.
(5) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Federal, state, county,
city, and tribal law enforcement
agencies.
Abstract: In November 1993, the
Brady Handgun Violence Prevention
Act of 1993 (Brady Act), Public Law
103–159, was signed into law and
required federal firearms licensees (FFL)
to request background checks on
individuals attempting to purchase or
receive a firearm. The permanent
provisions of the Brady Act, which went
into effect on November 30, 1998,
required the United States Attorney
General to establish a NICS that FFLs
may contact by telephone, or other
electronic means in addition to
telephone. for information to be
supplied immediately on whether the
receipt of a firearm by a prospective
transferee would violate Section 922 (g)
or (n) of Title 18, United States Code, or
state law. There are additional
authorized uses of the NICS found at
Title 28, Code of Federal Regulation
(CFR), Section 25.6(j). The FBI
authorized the CJAs to initiate a NICS
check to assist their transfer of firearms
to private individuals as a change to
28.CFR§ 25.6(j) in the Federal Register,
Volume 78, Number 18 pages 5757–
5760.
(6) An estimate of the total number of
respondents and the amount of time
E:\FR\FM\24JYN1.SGM
24JYN1
]]>Agencies
[Federal Register Volume 85, Number 143 (Friday, July 24, 2020)]
[Notices]
[Pages 44924-44925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16104]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-686]
Bulk Manufacturer of Controlled Substances Application: Ampac
Fine Chemicals LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before September 22,
2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 12, 2020, Ampac Fine Chemicals LLC, Highway 50
and Hazel Avenue, Rancho Cordova, California 95670, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substances:
[[Page 44925]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Methylphenidate........................ 1724 II
Levomethorphan......................... 9210 II
Levorphanol............................ 9220 II
Thebaine............................... 9333 II
Remifentanil........................... 9739 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for distribution to its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-16104 Filed 7-23-20; 8:45 am]
BILLING CODE 4410-09-P
